MULROY MICHAEL H. purchased 15.5% of their position (40K shares) of LINEAGE CELL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $22.6K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/25/2024ACC: 0000950170-24-130592
Director
Since Jul 2018
+40K
Net shares
Net buyer
$22.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
40K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+40K
Price / share
$0.57
Trade value
$22.64K
% of position
15.5%
11/22/2024
258.56K→298.56K
Total
Net shares
+40K
Net value
$22.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 11/22/2024 | P · Purchase | +40K | $0.57 | $22.64K | 15.5% | 258.56K | 298.56K |
| Total | +40K | $22.64K | ||||||
Derivative Transactions0
No derivative transactions reported